Jabra Enhance Plus vs Resound Vivia 9 60S microRIE

The Jabra Enhance Plus is a mid-priced OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.9/5. This places it in the top 27% of OTC hearing aids in our lab testing, ranking #18 of 63 devices in its category. In our testing, the Enhance Plus demonstrates notable strengths in speech clarity and audio streaming. Speech in quiet scores a strong 4.1/5, sitting +1.46 points above the category average. Music streaming quality also impresses at 3.8/5, outperforming the category average by +1.87 points—a standout result for an OTC device at this price point. Feedback handling is excellent at 4.7/5, meaning wearers should experience minimal whistling issues. The significant limitation is own-voice comfort, which scores just 0.3/5—a low result that falls -2.19 points below the category average. This suggests noticeable occlusion effects when speaking. Speech in noise performance is mixed at 2.5/5 in absolute terms, though this still sits +1.37 points above the category average, reflecting the broader challenges OTC devices face in noisy environments. The Jabra Enhance Plus is best suited for users who prioritize speech clarity in quieter settings and high-quality music/phone streaming, and who can tolerate some own-voice occlusion. Those frequently in noisy environments or particularly sensitive to hearing their own voice amplified may want to consider alternatives. Within its price range, competitors like the Sony CRE-E10 and Lexie B2 Plus achieve higher overall scores.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates notable strengths in speech clarity during quiet listening situations, scoring 4.0/5—a strong result that sits 0.57 points above the category average. Own-voice comfort is another highlight, measuring 0.65 points above average at 3.4/5, which may appeal to users sensitive to how their own speech sounds while wearing hearing aids. However, the Vivia 9 shows limitations in challenging acoustic environments. Speech-in-noise performance scores just 1.3/5, falling 0.25 points below the category average—a consideration for those frequently in noisy restaurants or social gatherings. Feedback handling, while strong in absolute terms at 4.2/5, measures 0.51 points below what other prescription devices achieve on average. Music streaming performance is mixed at 2.6/5, essentially matching the category norm. The Vivia 9 includes modern conveniences: rechargeable batteries, direct streaming to both iPhone and Android devices, and hands-free calling capability. Buyers seeking top-tier performance in this price range may want to compare alternatives like the Oticon Intent or Phonak Sphere Infinio, which scored notably higher in our testing. The Vivia 9 is best suited for users who prioritize clear speech in quieter settings and natural own-voice perception over challenging noise performance.